Press Releases
10.01.2023
BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform
Technology
Corporate
Show Article
09.01.2023
Key Leadership Appointments at BRAIN Biotech AG, Zwingenberg Site
Corporate
Show Article
17.11.2022
MP Beteiligungs-GmbH Increases Stake in BRAIN Biotech AG
Corporate
Show Article
25.10.2022
BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides
Corporate
Technology
Show Article
27.09.2022
Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand
Corporate
Show Article
26.09.2022
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
Corporate
Show Article
29.08.2022
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
Finance
Show Article
20.06.2022
BRAIN Biotech publishes first ESG and Sustainability Report
Corporate
Show Article
30.05.2022
BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting
Finance
Show Article